Earnings Estimates

Glossary »

Stock Information

Price (Prev Close) 116.93
Price - 52 Week High 127.64
Price - 52 Week Low 94.42
Price Date (Latest) May 22, 2017
Median Price Target 147.00
Diff from Prev Close 30.07
% Difference 25.72%

 

Analyst Ratings

1 Strong Buy 11
2 Buy 11
3 Hold 5
4 Underperform 1
5 Sell 0

Mean Recommendation: 1.86

Reference Information

Last Actual (FY0) 5.94
FY0 End Date Dec '16
Indicated Annual Div. N/A
Hist (5 Yr) Growth % 24.86 %
Hist (5 Yr) Stability % 2.81 %
Yield (%) N/A

 

Analyst Forecasts

Last Month Revisions
Fiscal Period Mean High Low Median # of Estimates # Up # Down Mean % Change
Annual
Dec '19
10.67 12.22 9.39 10.74 20 6 7 0.88 %
Annual
Dec '18
8.81 9.60 8.10 8.85 25 13 7 0.30 %
Annual
Dec '17
7.28 7.73 7.12 7.27 26 18 3 0.84 %
Quarterly
Jun '17
1.78 1.89 1.70 1.77 22 9 11 0.72 %
Quarterly
Sep '17
1.88 2.01 1.82 1.87 22 8 12 0.58 %
Quarterly
Dec '17
1.97 2.14 1.86 1.97 22 8 9 0.30 %
Quarterly
Mar '18
1.99 2.17 1.87 1.96 6 3 2 0.69 %
Long Term Growth
N/A
20.71 27.18 13.09 21.85 10 1 6 -5.00 %

 

Actuals

Fiscal Period Reported EPS Mean Estimate Surprise % Change
Annual
Dec '16
5.94 5.92 0.27 %
Quarterly
Jun '16
1.44 1.38 3.98 %
Quarterly
Sep '16
1.58 1.48 6.85 %
Quarterly
Dec '16
1.61 1.59 0.97 %
Quarterly
Mar '17
1.68 1.63 2.98 %
Annual
Dec '15
4.71 4.76 -0.95 %
Annual
Dec '14
3.71 3.69 0.52 %

 

P/E Ratios

Celgene Corporation - biotechnology

Fiscal Period Celgene Corporation biotechnology Industry Relative
FY0 19.69 51.34 0.38
FY1 16.06 54.44 0.29
FY2 13.28 37.43 0.35

 

Growth Rates

Celgene Corporation - biotechnology

Fiscal Period Celgene Corporation biotechnology Industry Relative
FY1/FY0 22.60 -6.12 1.31
FY2/FY1 20.93 42.83 0.85
FY3/FY2 21.16 46.43 0.83

Disclaimer: Mean earnings estimates are calculated by First Call based on their earnings projections made by the analysts who cover Celgene Corporation. Please note that any opinions, estimates or forecasts regarding Celgene Corporation's performance made by these analysts (and therefore the average estimate numbers) are theirs and do not represent opinions, forecasts or predictions of Celgene Corporation or its management. Celgene Corporation does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Prices are in USD